Pfizer to explore strategic alternatives for its Animal Health and Nutrition businesses
Pfizer Inc. today announced that it is exploring strategic alternatives for its Animal Health and Nutrition businesses based on its recent business portfolio review to determine the optimal mix of businesses for maximizing shareholder value.
Pfizer Inc. is leaning toward a spinoff of its animal health business, viewing a sale as less compelling because of a potentially heavy tax bill and antitrust scrutiny, people familiar with the matter said.